| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |